Article
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.
Cancer science - 1 May 2022
Kobayashi Kato Mayumi, Asami Yuka, Takayanagi Daisuke, Matsuda Maiko, Shimada Yoko, Hiranuma Kengo, Kuno Ikumi, Komatsu Masaaki, Hamamoto Ryuji, Matsumoto Koji, Ishikawa Mitsuya, Kohno Takashi, Kato Tomoyasu, Shiraishi Kouya, Yoshida Hiroshi
Abstract excerpt
To identify prognostic factors in patients with grade 3 (high-grade) endometrial endometrioid carcinoma, we evaluated the spectrum of genomic alterations and examined whether previously reported molecular subtypes of endometrial carcinoma were adapted to clinical outcome prediction. Seventy-five Japanese patients with grade 3 endometrial endometrioid carcinoma, who underwent a potentially curative resection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.